RESTRICTED TO EDITORIAL USE - A picture

RESTRICTED TO EDITORIAL USE - A picture taken on June 9, 2011 in a pharmacy of the northern city of Lille, shows blister packs of Actos antidiabetic drugs (Pioglitazone). Actos/Competact antidiabetic drugs from Takeda Japanese laboratory, responsible of a significant increase of bladder cancer for men, are "immediately banned form the market" in France, as reported on June 9, 2011 by Dominique Maraninchi, head of French Afssaps drug agency. AFP PHOTO / PHILIPPE HUGUEN (Photo credit should read PHILIPPE HUGUEN/AFP via Getty Images)
RESTRICTED TO EDITORIAL USE - A picture taken on June 9, 2011 in a pharmacy of the northern city of Lille, shows blister packs of Actos antidiabetic drugs (Pioglitazone). Actos/Competact antidiabetic drugs from Takeda Japanese laboratory, responsible of a significant increase of bladder cancer for men, are "immediately banned form the market" in France, as reported on June 9, 2011 by Dominique Maraninchi, head of French Afssaps drug agency. AFP PHOTO / PHILIPPE HUGUEN (Photo credit should read PHILIPPE HUGUEN/AFP via Getty Images)
RESTRICTED TO EDITORIAL USE - A picture
PURCHASE A LICENCE
How can I use this image?
£375.00
GBP

DETAILS

Restrictions:
Contact your local office for all commercial or promotional uses. Full editorial rights UK, US, Ireland, Italy, Spain, Canada (not Quebec). Restricted editorial rights elsewhere, please call local office.RESTRICTED TO EDITORIAL USE
Credit:
PHILIPPE HUGUEN / Staff
Editorial #:
117298119
Collection:
AFP
Date created:
09 June, 2011
Upload date:
Licence type:
Rights-managed
Release info:
Not released. More information
Source:
AFP
Barcode:
AFP
Object name:
Par6322659